The Role Of Bisphenol A In The Development Of Chronic Disease
Funder
National Health and Medical Research Council
Funding Amount
$397,549.00
Summary
There is accumulating evidence to suggest that the environment we live in may be important in the development of chronic disease. This project examines a key environmental toxin Bisphenol A (BPA) and explores the role it has in the development of diabetes, obesity and cardiovascular disease (CVD). In this project, we will explore whether there is an independent relationship between BPA and the development of diabetes, CVD and obesity in humans in a prospective setting.
Genetic Epidemiology Of Endometrial Cancer: Towards Understanding Aetiology And Improving Risk Prediction.
Funder
National Health and Medical Research Council
Funding Amount
$353,573.00
Summary
Studies investigating thousands of genetic markers have revolutionised our understanding of genes involved in cancer, and shown that a single gene can be associated with multiple cancers. We will conduct the largest ever study to find new genes for endometrial cancer, the most common gynaecological cancer. Our unique approach will examine >11million markers across the genome, some specifically in regions known to be important for other cancers. Findings will be used for risk prediction models ....Studies investigating thousands of genetic markers have revolutionised our understanding of genes involved in cancer, and shown that a single gene can be associated with multiple cancers. We will conduct the largest ever study to find new genes for endometrial cancer, the most common gynaecological cancer. Our unique approach will examine >11million markers across the genome, some specifically in regions known to be important for other cancers. Findings will be used for risk prediction models.Read moreRead less
Combating Infectious Diseases: Eco-Epidemiology, Disease Mapping, And Travel Medicine
Funder
National Health and Medical Research Council
Funding Amount
$344,644.00
Summary
Infectious disease outbreaks are driven by complex interactions between humans, animals, vectors, and the environment. Globally, outbreaks have been increasing in frequency and magnitude, e.g. Ebola and SARS. There is an urgent need to improve public health intelligence by accurately identifying the causes, timing, and hotspots. This project will develop advanced modelling strategies for improving our understanding of outbreaks, and optimise public health interventions to protect human health.
Harnessing Multiple Large Datasets To Answer Critical Questions On Diabetes Epidemiology
Funder
National Health and Medical Research Council
Funding Amount
$631,370.00
Summary
This proposal will examine novel causes and consequences of diabetes using three approaches. Firstly, it will examine diabetes trends. Secondly, it will use the Australian Diabetes Registry linked to several key government database to explore important research questions, related to diabetes treatment, dementia and endstage kidney disease, which previously were not able to be answered. Thirdly, it will examine the role of environmental pollutants in the development of chronic disease.
Prospective Study Of Birth Defects From Fetotoxic Agents In The Public Water Supply
Funder
National Health and Medical Research Council
Funding Amount
$732,036.00
Summary
Recent research in Australia & internationally shows that birth defects are more common in areas where mothers are exposed to poor quality drinking water, particularly when treatment chemicals known as trihalomethanes (THMs) are present. We will determine the risk that high THM levels pose to unborn babies by accurately measuring individual exposures to THMs & correlating these with adverse birth outcomes. The study will be in Perth where THM levels are very high in a number of suburbs.
Assessing maternal exposure to persistent toxic substances and risk of adverse birth outcomes. There are numerous sources of persistent toxic substances (PTS) and due to their long half life in the environment they can increase in concentration over time, increasing the risks of human exposure. Australia is a signatory to the Stockholm Convention and this project both assists in the meeting Australia's obligations but also addresses the important subject of the relationship between environment, ....Assessing maternal exposure to persistent toxic substances and risk of adverse birth outcomes. There are numerous sources of persistent toxic substances (PTS) and due to their long half life in the environment they can increase in concentration over time, increasing the risks of human exposure. Australia is a signatory to the Stockholm Convention and this project both assists in the meeting Australia's obligations but also addresses the important subject of the relationship between environment, health and risk. The study will be the first of its type to systematically measure maternal exposure and link the risk of adverse birth outcomes. It will significantly improve our ability to assess the impact of chemicals on health. It will also provide benchmark information for a use in national standard setting and policy development. Read moreRead less
Novel Genetic And Environmental Modifiers Of The Risk Of Iron Overload-related Disease In HFE-associated Hereditary Haemochromatosis In Cohort Of Middle-aged Australians
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
People who carry mutations in the HFE gene are pre-disposed to body iron overload but not all of them developed subsequent disease. According to the investigators of the “HealthIron” study in Melbourne, only 28% of men and 1% of women with faulty HFE genes go on to develop disease. This study has recruited more than 1,000 people from the community, and will determine which environmental and genetic risk factors stop people with iron overload from getting symptoms of disease.
Environmental Risk Factors For Primary Progressive Multiple Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$86,118.00
Summary
Primary Progressive Multiple Sclerosis (PPMS) is a form of MS affecting 10% of people with the disease. PPMS has been less researched than the more common form of MS, Relapsing Remitting MS (RRMS), and unlike RRMS, there are currently no effective treatments. This project will examine whether the established risk factors for RRMS also hold for PPMS, whether the magnitude of risk associated with these factors is the same for PPMS, and whether novel risk factors for PPMS can be identified.